Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

PTSF77 – Progress and Context, with Jesse Gould of the Heroic...

Awakn Life Sciences to Acquire Leading Ketamine-Assisted Psychotherapy Clinic in Norway

Former Compass Interim Clinical Sciences Director Joins Clerkenwell Health as CMO

MINDCURE Joins Digital Therapeutics Alliance to Drive Innovation in the Mental...

Awakn Life Sciences Reports Second Quarter 2021 Financial Results and Business...

Nova Mentis Applies to US FDA for Psilocybin Orphan Drug Designation...

Understanding ‘Spiritual Emergency’ in the Context of Psychedelics

atai Life Sciences Increases Loan in Principal by US$6m to Support...

Small Pharma Announces Engagement of Investor Relations Provider

Fear of Death Impacts Quality of Life-How Psychedelics Can Help

1...196197198...218 Page 197 of 218

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin